LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Manufacturing Facility
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • IR Inquiries

Star Actress Choi Jiwoo Stores Her Baby’s Umbilical Cord Blood Unit at MEDIPOST’s CELLTREE

2020/05/18
CORD BLOOD BANK

Longer-Term Storage of Cord Blood Gains Popularity Over 20,000 Cumulative Cases at CELLTREE

2020/04/29
CORD BLOOD BANK

Korean Star Couple Rain and Kim Tae-hee Bank Baby’s Cord Blood in MEDIPOST

2017/10/25
CORD BLOOD BANK

Russian Representatives of the Korea-Russia Healthcare Cooperation Group Visit MEDIPOST

2017/07/26
CORD BLOOD BANK

MEDIPOST Signs Agreement with Thailand’s Inter Stemma for Establishing and Operating Cord Blood Bank in Thailand

2016/10/04
CORD BLOOD BANK

Younger Brother’s Cord Blood Used for Treating Older Brother’s Malignant Hemopathy

2016/09/27
CORD BLOOD BANK

MEDIPOST’s Cord Blood Bank, CELLTREE Evaluated ‘Suitable’ in All Areas by the Ministry of Health and Welfare

2016/02/12
CORD BLOOD BANK

U.S. Embassy made an industrial observation trip to MEDIPOST cord blood facilities etc.

2015/08/17
CORD BLOOD BANK

Quantity of Cord Blood under Custody Exceeds 200,000 Units for the First Time in Korea

2015/01/27
CORD BLOOD BANK

Hiddink, designated MEDIPOST Cord Blood Honorary Ambassador

2014/07/23
CORD BLOOD BANK

Latest News

MEDIPOST Enhances its Partnership with Canada’s OmniaBio in Collaboration for the CMDO Business of OmniaBio’s All-Around Cell and Gene Therapy.
2022/12/01
Medipost to launch a CDMO business for cell and gene therapy products in Korea based on 20 years of research and production knowledge
2022/10/17
Canada’s OmniaBio, MEDIPOST affiliate begins CDMO cGMP for cell gene therapy
2022/10/07
MEDIPOST’s 5-year follow-up of phase 3 clinical trial patients receives 2021 OJSM award
2022/07/18
Medipost enters North American market by acquiring OmniaBio, a CDMO company with cell and gene therapy products
2022/05/31

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

CS CENTER
ONLINE INQUIRY

Latest News

·
MEDIPOST Enhances its Partnership with Canada’s OmniaBio in Collaboration for the CMDO Business of OmniaBio’s All-Around Cell and Gene Therapy.2022.12.01
·
Medipost to launch a CDMO business for cell and gene therapy products in Korea based on 20 years of research and production knowledge2022.10.17
·
Canada’s OmniaBio, MEDIPOST affiliate begins CDMO cGMP for cell gene therapy2022.10.07
·
MEDIPOST’s 5-year follow-up of phase 3 clinical trial patients receives 2021 OJSM award2022.07.18
·
Medipost enters North American market by acquiring OmniaBio, a CDMO company with cell and gene therapy products2022.05.31

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST